Extensive study identifies over a dozen existing drugs as potential COVID-19 therapies

Good news! Very interesting research into whether existing drugs can be repurposed to treat e.g. Covid-19. 

"Mining the world’s most comprehensive drug repurposing collection for COVID-19 therapies, scientists have identified 90 existing drugs or drug candidates with antiviral activity against the coronavirus that’s driving the ongoing global pandemic.

Among those compounds, the Scripps Research study identified four clinically approved drugs and nine compounds in other stages of development with strong potential to be repurposed as oral drugs for COVID-19, according to results published June 3 in the journal Nature Communications. ...

the study tested more than 12,000 drugs in two different types of human cells infected with SARS-CoV-2. ...

In the ... study, the scientists treated two different types of laboratory-cultured SARS-CoV-2-infected human cells with each of the 12,000 drugs ... After 24 or 48 hours, they measured the level of viral infection in the cells to determine if the drugs prevented the virus from replicating. In some cases, they applied two drugs at a time to see if the compounds would work together against the virus. ..."

Extensive study identifies over a dozen existing drugs as potential COVID-19 therapies | Scripps Research FDA-approved drugs or experimental drugs with ample health data could be rapidly tested in humans for treatment of COVID-19.

Here is the link to the underlying research article:

Drug repurposing screens identify chemical entities for the development of COVID-19 interventions (open access)